Synthesis of selective PAK4 inhibitors for lung metastasis of lung cancer and melanoma cells-Reference-Cited by-同舟云学术

Synthesis of selective PAK4 inhibitors for lung metastasis of lung cancer and melanoma cells

Published:2022-06 Issue:6 Volume:12 Page:2905-2922
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Song Peilu,Zhao Fan^ORCID,Li Dahong^ORCID,Qu Jiqiang,Yao Miao,Su Yuan,Wang Hanxun,Zhou Miaomiao,Wang Yujie,Gao Yinli^ORCID,Li Feng,Zhao Dongmei,Zhang Fengjiao,Rao Yu,Xia Mingyu^ORCID,Li Haitao,Wang Jian,Cheng Maosheng^ORCID

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference57 articles.

1. The p21Rac/Cdc42-activated kinases (PAKs);Knaus;Int J Biochem Cell Biol,1998

2. A tale of two PAKs;Arias-Romero;Biol Cell,2008

3. PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia;Abo;EMBO J,1998

4. Structure, biochemistry, and biology of PAK kinases;Kumar;Gene,2017

5. Inhibitors of p21-activated kinases (PAKs);Rudolph;J Med Chem,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting SMAD-Dependent Signaling: Considerations in Epithelial and Mesenchymal Solid Tumors;Pharmaceuticals;2024-03-01

2. Anti-collagenase, Anti-elastase, Anti-urease, and Anti-cancer Potentials of Isokaempferide as Natural Compound: <i>In vitro</i> and <i>in silico</i> Study;Journal of Oleo Science;2024

3. Design and Characterization of a Novel eEF2K Degrader with Potent Therapeutic Efficacy Against Triple‐Negative Breast Cancer;Advanced Science;2023-12-12

4. Nanotechnology-empowered lung cancer therapy: From EMT role in cancer metastasis to application of nanoengineered structures for modulating growth and metastasis;Environmental Research;2023-09

5. The mirrored cationic peptide as miRNA vehicle for efficient lung cancer therapy;MedComm;2023-07-28